ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,931Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 680

$1.4M Total Retail Price of All Prescriptions

Rank: 29 out of 680

1,202 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,202 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

25% of this provider’s 1,202 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 17,060 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,624 1,033 S3 1 4
AMLODIPINE BESYLATE 669 611 2 1
OMEPRAZOLE 610 511 3 7
ALPRAZOLAM 603 465 4 72
PRAVASTATIN SODIUM 594 511 5 10
LEVOTHYROXINE SODIUM 577 506 6 2
ZOLPIDEM TARTRATE 567 395 7 17
FUROSEMIDE 345 290 8 6
FENOFIBRATE 342 292 9 66
METOPROLOL TARTRATE 333 276 10 12
TEMAZEPAM 328 295 11 155
BENAZEPRIL HCL 324 272 12 40
SIMVASTATIN 313 276 13 3
LISINOPRIL 309 260 14 5
METFORMIN HCL 302 259 15 8
PANTOPRAZOLE SODIUM 298 244 16 30
WARFARIN SODIUM 290 257 17 20
ATORVASTATIN CALCIUM 281 239 18 11
GLIMEPIRIDE 280 244 19 29
LOSARTAN POTASSIUM 275 249 20 21
NEXIUM 264 167 21 16
CITALOPRAM HBR 255 190 22 22
ENALAPRIL MALEATE 247 197 23 65
AMLODIPINE BESYLATE-BENAZEPRIL 240 177 24 43
GABAPENTIN 236 154 25 15
ATENOLOL 221 185 26 19
CLONAZEPAM 217 131 27 190
POTASSIUM CHLORIDE 200 158 28 14
METFORMIN HCL ER 187 148 29 54
LORAZEPAM 186 149 30 125
HYDROCHLOROTHIAZIDE 184 165 31 9
LOVASTATIN 182 162 32 44
CYMBALTA 181 93 33 46
METOPROLOL SUCCINATE 170 128 34 13
TAMSULOSIN HCL 165 149 35 34
RANITIDINE HCL 156 138 36 56
DIOVAN 152 129 37 31
SERTRALINE HCL 146 130 38 28
FLUTICASONE PROPIONATE 146 106 38 41
LYRICA 145 83 40 77
MELOXICAM 143 130 41 24
CARVEDILOL 137 130 42 23
ESCITALOPRAM OXALATE 132 77 43 45
CARISOPRODOL 131 42 R 44 83
TRAMADOL HCL 126 85 45 18
PROAIR HFA 123 84 46 67
ALLOPURINOL 121 107 47 33
DONEPEZIL HCL 119 118 48 27
ZOSTAVAX 118 110 49 230
NAMENDA 112 109 50 35
ALENDRONATE SODIUM 111 94 51 32
TRAZODONE HCL 96 58 52 48
ADVAIR DISKUS 95 75 53 53
DIOVAN HCT 93 64 54 55
SYNTHROID 93 88 54 38
MORPHINE SULFATE ER 91 48 S2 56 198
CELEBREX 89 79 57 90
AMITRIPTYLINE HCL 89 55 R 57 47
LANSOPRAZOLE 85 76 59 184
OXYCODONE-ACETAMINOPHEN 85 71 S2 59 215
INSULIN SYRINGE 84 72 61 86
DIAZEPAM 83 64 62 188
PREDNISONE 83 75 62 50
PLAVIX 83 77 62 39
OXYCODONE HCL-ACETAMINOPHEN 83 42 S2 62 133
CRESTOR 82 60 66 25
CIPROFLOXACIN HCL 81 69 67 57
ISOSORBIDE MONONITRATE ER 80 80 68 59
CLOPIDOGREL 79 69 69 26
SYMBICORT 76 61 70 208
AZITHROMYCIN 76 60 70 42
FENTANYL 74 59 S2 72 183
SPIRIVA 71 47 73 70
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 54 74 94
ROPINIROLE HCL 65 48 75 99
TRIAMTERENE-HCTZ 65 48 75 52
TRAMADOL HCL-ACETAMINOPHEN 65 51 75 153
OXYBUTYNIN CHLORIDE ER 61 45 78 143
CLONIDINE HCL 59 55 79 36
POLYETHYLENE GLYCOL 3350 58 44 80 62
TORSEMIDE 56 39 81 163
DIGOXIN 54 53 82 58
MUPIROCIN 54 29 82 130
CYCLOBENZAPRINE HCL 53 19 R 84 81
METHYLPREDNISOLONE 52 35 85 93
IRBESARTAN 51 49 86 247
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 43 87 37
LANTUS SOLOSTAR 50 28 87 84
TROSPIUM CHLORIDE 50 50 87 463
DOXAZOSIN MESYLATE 50 44 87 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.